Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L42 pseudogene 1 (MRPL42P1) is a processed pseudogene located in the human genome. Pseudogenes such as MRPL42P1 arise from duplication or retrotransposition events of functional genes, but they lack the capability to produce a functional protein due to mutations, truncations, or loss of regulatory elements. MRPL42P1 does not code for a functional mitochondrial ribosomal protein and has no known biological or therapeutic role. Its canonical parent gene, MRPL42, encodes a component of the mitochondrial ribosome important for mitochondrial protein synthesis, but the pseudogene itself is considered nonfunctional. There are no known aliases, disease associations, or drug interactions for MRPL42P1. It is not considered a valid therapeutic target.
None, as it is not a recognized drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L42 pseudogene 1 (MRPL42P1).